Pulmonary Hypertension Complicating Pregnancy

Abstract Purpose of review This study aims to describe the pathophysiology pregnancy in pulmonary hypertension (PH) and recent literature on maternal fetal outcomes. Recent findings There is an increasing number pregnant women with PH. Maternal mortality arterial (PAH) ranges from 9 25%, most commonly heart failure arrythmias. The highest risk death peri-partum post-partum. Fetal/neonatal morbidity are also substantial. high rates prematurity, intrauterine growth retardation, preeclampsia. Women should be referred expert centers for management. Combination PAH therapy parenteral prostacyclin a phosphodiesterase type V inhibitor recommended. Induced vaginal delivery preferred, except cases severe or obstetric indications cesarean section. Summary Despite advances management, remains high-risk condition prevented.